AMA Comments on Implications of RFID

The American Medical Association’s Council on Ethical and Judicial Affiars recently published a report (doc) “Radio Frequency ID Devices in Humans”. The report includes the AMA’s recommendations in light of the current available data which describes RFID capabilities and limitations. The group particularly considers the impact of active RFID tags, rather than passive devices which can only transmit data within a limited range.

One of the organization’s first concerns is the overall safety of implanting devices. Current design iterations are as small as a grain of rice, which may become displaced following insertion. The tags may also interfere with other implanted devices that use electromagnetic components. A final consideration is the effect of RFID implants on drug therapy, as the tool may modify pharmacokinetics or otherwise change the drug.

The report further addresses privacy and ethical considerations; security of the devices has yet to be conclusively proven. In light of such, the AMA advocates for devices which include appropriate security measures to protect patient information.

The report also mentions one of the practical considerations as RFID continues to enter the healthcare industry; device compatability with readers. Continued design efforts may fail in the healthcare field if either the interrogators or tags, particularly for human implantation, cannot be read due to differences in technology.

The report clearly demonstrates interest in the potential capabilities of RFID to improve patient safety, but notes the much needed further studies to ensure both device safety for patients and security of data.

Hospital Buyer

News for healthcare procurement decision makers